文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

嗜酸性粒细胞性食管炎和胃肠炎

Eosinophilic Esophagitis and Gastroenteritis.

作者信息

Cianferoni Antonella, Spergel Jonathan M

机构信息

Division of Allergy and Immunology, The Children's Hospital of Philadelphia, Perelman School of Medicine at University of Pennsylvania, 3615 Civic Center Boulevard, Philadelphia, PA, 19104-4399, USA,

出版信息

Curr Allergy Asthma Rep. 2015 Sep;15(9):58. doi: 10.1007/s11882-015-0558-5.


DOI:10.1007/s11882-015-0558-5
PMID:26233430
Abstract

Eosinophilic gastrointestinal disease (EGID) can be classified as eosinophilic esophagitis (EoE) when the eosinophilia is limited to the esophagus or as eosinophilic gastritis (EG) if it is limited to the gastric tract, eosinophilic colitis (EC) if it is limited to the colon, and eosinophilic gastroenteritis (EGE) if the eosinophilia involves one or more parts of the gastrointestinal tract. EoE is by far the most common EGID. It is a well-defined chronic atopic disease due to a T helper type 2 (Th2) inflammation triggered often by food allergens. EoE diagnosis is done if an esophageal biopsy shows at least 15 eosinophils per high power field (eos/hpf). Globally accepted long-term therapies for EoE are the use of swallowed inhaled steroids or food antigen avoidance. The treatment of EoE is done not only to control symptoms but also to prevent complications such as esophageal stricture and food impaction. EGE cause non-specific gastrointestinal (GI) symptoms and are diagnosed if esophagogastroduodenoscopy (EGD)/colonoscopy show eosinophilia in one or more parts of the GI tract. They are rare diseases with an unclear pathogenesis, and they are poorly defined in terms of diagnostic criteria and treatment. Before initiating treatment of any EGE, it is imperative to conduct a differential diagnosis to exclude other causes of hypereosinophilia with GI localization. EGE are often poorly responsive to therapy and there is no commonly accepted long-term treatment. EG has many characteristics similar to EoE, including the fact that it is often due to a food allergen-driven Th2 inflammation; transcriptome analysis however shows that it is more a systemic disease and has a different gene signature than EoE. EC is a benign form of delayed food allergy in infant and is instead a difficult-to-treat severe inflammatory condition in older children and adults. EC in the latter groups can be a manifestation of drug allergy or autoimmune disease. Overall EGE, EC, and EG are rare and are a diagnosis of exclusion until more common causes of eosinophilia have been excluded.

摘要

嗜酸性粒细胞性胃肠道疾病(EGID),若嗜酸性粒细胞增多仅限于食管,则可分类为嗜酸性粒细胞性食管炎(EoE);若仅限于胃肠道,则为嗜酸性粒细胞性胃炎(EG);若仅限于结肠,则为嗜酸性粒细胞性结肠炎(EC);若嗜酸性粒细胞增多累及胃肠道的一个或多个部位,则为嗜酸性粒细胞性胃肠炎(EGE)。EoE是迄今为止最常见的EGID。它是一种明确的慢性特应性疾病,由食物过敏原引发的2型辅助性T(Th2)炎症所致。如果食管活检显示每高倍视野至少有15个嗜酸性粒细胞(eos/hpf),则可诊断为EoE。全球公认的EoE长期治疗方法是使用吞咽吸入性类固醇或避免食物抗原。EoE的治疗不仅是为了控制症状,也是为了预防诸如食管狭窄和食物嵌塞等并发症。EGE会引起非特异性胃肠道(GI)症状,如果食管胃十二指肠镜检查(EGD)/结肠镜检查显示胃肠道的一个或多个部位有嗜酸性粒细胞增多,则可诊断为EGE。它们是罕见疾病,发病机制尚不清楚,在诊断标准和治疗方面定义不明确。在开始任何EGE治疗之前,必须进行鉴别诊断,以排除其他伴有胃肠道定位的嗜酸性粒细胞增多的原因。EGE通常对治疗反应不佳,且没有普遍接受的长期治疗方法。EG有许多与EoE相似的特征,包括它通常由食物过敏原驱动的Th2炎症引起;然而,转录组分析表明,它更像是一种全身性疾病,并且与EoE有不同的基因特征。EC在婴儿中是迟发性食物过敏的一种良性形式,而在大龄儿童和成人中则是一种难以治疗的严重炎症性疾病。后一组中的EC可能是药物过敏或自身免疫性疾病的表现。总体而言,EGE、EC和EG都很罕见,在排除嗜酸性粒细胞增多的更常见原因之前,它们都是排除性诊断。

相似文献

[1]
Eosinophilic Esophagitis and Gastroenteritis.

Curr Allergy Asthma Rep. 2015-9

[2]
Eosinophilic Gastrointestinal Diseases in Childhood.

Ann Nutr Metab. 2019-2-19

[3]
Limited role of allergy testing in patients with eosinophilic gastrointestinal disorders.

J Gastroenterol Hepatol. 2013-8

[4]
Primary Eosinophilic Gastrointestinal Diseases Beyond Eosinophilic Esophagitis in Children.

J Pediatr Gastroenterol Nutr. 2021-2-1

[5]
Eosinophilic Esophagitis: A Comprehensive Review.

Clin Rev Allergy Immunol. 2016-4

[6]
Eosinophilic esophagitis and other eosinophilic disorders of the gastrointestinal tract.

Pediatr Allergy Immunol. 2020-2

[7]
Eosinophilic Gastritis and Enteritis Are Increased in Families With Eosinophilic Esophagitis.

Am J Gastroenterol. 2023-2-1

[8]
Elements Involved In Promoting Eosinophilic Gastrointestinal Disorders.

J Genet Syndr Gene Ther. 2015-8

[9]
Eosinophilic Gastrointestinal Disorders.

Clin Rev Allergy Immunol. 2019-10

[10]
Eosinophilic Esophagitis Clinical Manifestations and Differential Diagnosis.

Clin Rev Allergy Immunol. 2018-8

引用本文的文献

[1]
Age-Dependent Clinical Manifestations of Eosinophilic Gastrointestinal Disorders Beyond Eosinophilic Esophagitis.

J Asthma Allergy. 2025-5-15

[2]
A Patient With Eosinophilic Gastroenteritis Presenting With Severe Abdominal Pain.

Clin Case Rep. 2024-12-6

[3]
An efficient computational framework for gastrointestinal disorder prediction using attention-based transfer learning.

PeerJ Comput Sci. 2024-5-28

[4]
Clinical and atopic features of patients with primary eosinophilic colitis: an Italian multicentre study.

Intern Emerg Med. 2024-6

[5]
Identification of CXC Chemokine Receptor 2 (CXCR2) as a Novel Eosinophils-Independent Diagnostic Biomarker of Pediatric Eosinophilic Esophagitis by Integrated Bioinformatic and Machine-Learning Analysis.

Immunotargets Ther. 2024-2-2

[6]
Descriptive Analysis of Pre-existing Data on Eosinophilic Esophagitis and Associated Morbidities in Cleveland Clinic Abu Dhabi, United Arab Emirates.

Cureus. 2024-1-1

[7]
Nonatopic Eosinophilic Duodenitis in an Adult: A Case Report and Overview.

Cureus. 2023-8-22

[8]
Local type 2 immunity in eosinophilic gastritis.

J Allergy Clin Immunol. 2023-7

[9]
Update on eosinophilic gastrointestinal disease beyond eosinophilic esophagitis in children.

Clin Exp Pediatr. 2023-6

[10]
Mortality and cancer in eosinophilic gastrointestinal disorders distal to the esophagus: nationwide cohort study 1990-2017.

J Gastroenterol. 2022-10

本文引用的文献

[1]
Eosinophilic esophagitis and proton pump inhibitors: controversies and implications for clinical practice.

Gastroenterol Hepatol (N Y). 2014-7

[2]
Efficacy of Dietary Treatment for Inducing Disease Remission in Eosinophilic Gastroenteritis.

J Pediatr Gastroenterol Nutr. 2015-7

[3]
The changing faces of eosinophilic esophagitis: the impact of consensus guidelines at the University of South Florida.

Dig Dis Sci. 2015-6

[4]
Clinical characteristics, treatment outcomes, and resource utilization in children and adults with eosinophilic gastroenteritis.

Dig Liver Dis. 2015-3

[5]
Transcriptome analysis of proton pump inhibitor-responsive esophageal eosinophilia reveals proton pump inhibitor-reversible allergic inflammation.

J Allergy Clin Immunol. 2015-1

[6]
GWAS identifies four novel eosinophilic esophagitis loci.

Nat Commun. 2014-11-19

[7]
Histologic eosinophilic gastritis is a systemic disorder associated with blood and extragastric eosinophilia, TH2 immunity, and a unique gastric transcriptome.

J Allergy Clin Immunol. 2014-11

[8]
Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis.

J Allergy Clin Immunol. 2014-9-13

[9]
Relation between eosinophilic esophagitis and oral immunotherapy for food allergy: a systematic review with meta-analysis.

Ann Allergy Asthma Immunol. 2014-12

[10]
Eosinophilic esophagitis and proton pump-responsive esophageal eosinophilia: what is in a name?

Clin Gastroenterol Hepatol. 2014-12

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索